Headlines

Solar Capital Ltd. And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Solar Capital Ltd. (SLRC), Addus HomeCare Corporation (ADUS), ITT Corporation (ITT) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Solar Capital Ltd. (SLRC)

11.5% sales growth and 7.21% return on equity

Solar Capital Ltd. is a business development company specializing in secured debt (first lien unitranche and second lien), subordinated (unsecured) debt, minority equity, and strategic income-oriented control equity investments in leveraged middle market companies. The fund invests in aerospace and defense; air freight & logistics; asset management; automotive; banking; beverage, food and tobacco; building products; buildings and real estate; broadcasting and entertainment; cargo transport; commercial services and supplies; communications equipment; chemicals, plastics and rubber; containers, packaging and glass; construction & engineering; diversified/conglomerate manufacturing; consumer Finance; distributors; diversified/conglomerate services; diversified financial services; diversified real estate sctivities; food products; Footwear; Education Services; diversified telecommunications services; electronics; farming and agriculture; finance; grocery; health care equipment and supplies; health care facilities; education and childcare; home and office furnishing, durable consumer products; hotels, motels, inns and gaming; insurance; restaurants, leisure, amusement, and entertainment; leisure equipment tolls and services, media, multiline retail, multi sector holdings; paper and forest products; personal products; professional services, research and consulting services, software; specialty retail; textiles apparel and luxury goods, thrifts and mortgage finance, trading companies and distributors, utilities, and wireless telecommunication services; industrial conglomerates; internet software and services, IT services, machinery; mining, steel, iron, and non precious metals; oil and gas; personal, food and miscellaneous services; printing and publishing; retail stores; telecommunications; textiles and leather; and utilities. It also invests in life sciences with focus on specialty pharmaceuticals, medical devices, biotech, health Care Providers and services; health Care technology, enabling technologies and tools. The fund primarily invests in United States. The fund's investments generally range between $5 million and $100 million. The fund invests in companies with revenues between $50 million and $1 billion and EBITDA between $15 million and $100 million. It invests in the form of senior secured loans, mezzanine loans, and equity securities. It may also seek investments in thinly traded public companies and also make secondary investments. The fund makes non-control equity investments. It primarily exits within three years of the initial capital commitment.

Earnings Per Share

As for profitability, Solar Capital Ltd. has a trailing twelve months EPS of $1.33.

PE Ratio

Solar Capital Ltd. has a trailing twelve months price to earnings ratio of 11.46. Meaning, the purchaser of the share is investing $11.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.21%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Dec 12, 2023, the estimated forward annual dividend rate is 1.64 and the estimated forward annual dividend yield is 10.76%.

Moving Average

Solar Capital Ltd.’s value is higher than its 50-day moving average of $15.07 and above its 200-day moving average of $14.79.

Sales Growth

Solar Capital Ltd.’s sales growth is 9.9% for the present quarter and 11.5% for the next.

2. Addus HomeCare Corporation (ADUS)

10.7% sales growth and 8.88% return on equity

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Earnings Per Share

As for profitability, Addus HomeCare Corporation has a trailing twelve months EPS of $3.53.

PE Ratio

Addus HomeCare Corporation has a trailing twelve months price to earnings ratio of 25.1. Meaning, the purchaser of the share is investing $25.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.88%.

Moving Average

Addus HomeCare Corporation’s value is below its 50-day moving average of $89.00 and below its 200-day moving average of $90.93.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.6%, now sitting on 1.03B for the twelve trailing months.

Sales Growth

Addus HomeCare Corporation’s sales growth is 11.1% for the current quarter and 10.7% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Addus HomeCare Corporation’s EBITDA is 52.9.

3. ITT Corporation (ITT)

9.8% sales growth and 19.51% return on equity

ITT Inc. manufactures and sells engineered critical components and customized technology solutions for the energy, transportation, and industrial markets worldwide. The company operates through three segments: Motion Technologies, Industrial Process, and Connect & Control Technologies. The Motion Technologies segment manufactures brake pads, shims, shock absorbers, and energy absorption components; and sealing technologies primarily for the transportation industry, including passenger cars, light- and heavy-duty commercial and military vehicles, buses, and rail. The Industrial Process segment designs and manufactures industrial pumps, valves, and plant optimization systems; and centrifugal process pumps, twin screw, axials, and positive displacement pumps, and water systems, as well as aftermarket solutions, such as repairs and upgrades services. It serves various customers in industries, such as chemical, oil and gas, mining, and other industrial process markets. The Connect & Control Technologies segment designs and manufactures a range of engineered connectors and specialized control components for critical applications supporting various markets, including aerospace and defense, industrial, transportation, medical, and oil and gas. The connector product portfolio includes electrical connectors, such as circular, rectangular, radio frequency, fiber optic, D-sub miniature, micro-miniature, and cable assemblies; and control products consist of fuel and water pumps, valves, electro-mechanical rotary and linear actuators, and pressure, temperature, limit, and flow switches for various aircraft systems. ITT Inc. was founded in 1920 and is headquartered in White Plains, New York.

Earnings Per Share

As for profitability, ITT Corporation has a trailing twelve months EPS of $5.23.

PE Ratio

ITT Corporation has a trailing twelve months price to earnings ratio of 22.8. Meaning, the purchaser of the share is investing $22.8 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.51%.

Yearly Top and Bottom Value

ITT Corporation’s stock is valued at $119.23 at 00:22 EST, under its 52-week high of $121.89 and way higher than its 52-week low of $75.82.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ITT Corporation’s EBITDA is 46.89.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Nov 29, 2023, the estimated forward annual dividend rate is 1.16 and the estimated forward annual dividend yield is 0.97%.

4. H&E Equipment Services (HEES)

9.7% sales growth and 39.47% return on equity

H&E Equipment Services, Inc. operates as an integrated equipment services company. The company operates in five segments: Equipment Rentals, Used Equipment Sales, New Equipment Sales, Parts Sales, and Repair and Maintenance Services. The Equipment Rentals segment provides construction and industrial equipment for rent on a daily, weekly, and monthly basis through a fleet of approximately 42,725 pieces of equipment. The Used Equipment Sales segment sells used equipment through retail sales force primarily from its rental fleet, as well as inventoried equipment that are acquired through trade-ins from equipment customers. The New Equipment Sales segment sells new construction equipment through a professional in-house retail sales force. The Parts Sales segment sells parts for the equipment customers, as well as offers for its rental fleet. The Repair and Maintenance Services segment serves its rental fleet and equipment owned customers, as well as offers ongoing preventative maintenance services to industrial customers. It also provides ancillary equipment support activities, including transportation, hauling, parts shipping, and loss damage waivers. The company's rental fleet consists of hi-lift or aerial work platforms, cranes, earthmoving and material handling equipment, and others. It serves industrial and commercial companies, construction contractors, manufacturers, public utilities, municipalities, maintenance contractors, and various other industrial account customers. As of December 31, 2021, the company had a network of 102 service facilities in the Pacific Northwest, West Coast, Intermountain, Southwest, Gulf Coast, Southeast, and Mid-Atlantic regions of the United States. H&E Equipment Services, Inc. was founded in 1961 and is headquartered in Baton Rouge, Louisiana.

Earnings Per Share

As for profitability, H&E Equipment Services has a trailing twelve months EPS of $4.63.

PE Ratio

H&E Equipment Services has a trailing twelve months price to earnings ratio of 10.49. Meaning, the purchaser of the share is investing $10.49 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.47%.

Volume

Today’s last reported volume for H&E Equipment Services is 92457 which is 54.17% below its average volume of 201745.

Moving Average

H&E Equipment Services’s worth is above its 50-day moving average of $47.44 and way higher than its 200-day moving average of $43.84.

Yearly Top and Bottom Value

H&E Equipment Services’s stock is valued at $48.55 at 00:22 EST, way under its 52-week high of $56.47 and way above its 52-week low of $32.33.

Sales Growth

H&E Equipment Services’s sales growth is 8.3% for the current quarter and 9.7% for the next.

5. Edwards Lifesciences (EW)

7% sales growth and 22.06% return on equity

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Earnings Per Share

As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.34.

PE Ratio

Edwards Lifesciences has a trailing twelve months price to earnings ratio of 31.28. Meaning, the purchaser of the share is investing $31.28 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.06%.

Sales Growth

Edwards Lifesciences’s sales growth is 10.8% for the present quarter and 7% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 5.82B for the twelve trailing months.

Volume

Today’s last reported volume for Edwards Lifesciences is 2185990 which is 49.29% below its average volume of 4310890.

Yearly Top and Bottom Value

Edwards Lifesciences’s stock is valued at $73.18 at 00:22 EST, way under its 52-week high of $94.87 and way above its 52-week low of $60.57.

Leave a Reply

Your email address will not be published. Required fields are marked *